T
ASXC

TCWP’s Asensus Surgical, Inc. ASXC Stock Holding History

TCWP’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed – – 1863
2022
Q1 		$0 Buy
+1,000
New +$770 ﹤0.01% 1947

Other funds holding ASXC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCWP's ASXC Position: Q2 2022 in Review

TCWP sold out of Asensus Surgical, Inc. (ASXC) in Q2 2022, closing a stake of 1,000 shares.

TCWP first reported a position in ASXC in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 91 funds tracked by Wall St. Rank hold ASXC as of Q2 2022.

  • TCWP reported no remaining Asensus Surgical, Inc. position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 1,000 Asensus Surgical, Inc. shares in Q2 2022.
  • TCWP first reported a position in Asensus Surgical, Inc. in Q1 2022 and held it in 1 quarter.
  • TCWP's Asensus Surgical, Inc. position peaked at $0 in Q1 2022.
  • 91 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.